Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs YOURx Health

Alan Meds
Graded #99

Higher grade

vs+1.2999999999999972
YOURx Health
Graded #118

Lower grade

The verdict

Alan Meds takes it — 71.1/100 to 69.8/100, but only just.

Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options. YOURx Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlan Meds +6
72
66
Dose & formulationEven
75
75
Clinical oversightAlan Meds +2
82
80
Labs & monitoringYOURx Health +22
53
75
FulfillmentAlan Meds +23
78
55
Contract termsEven
55
55
Alan Meds · left barYOURx Health · right bar

The numbers

MetricAlan MedsYOURx Health
WeighScore71.1/10069.8/100
GradeCC
Scorecard rank#99#118
Semaglutide$158/mo (compounded)$179/mo (compounded)
Tirzepatide$295/mo (compounded)$199/mo (compounded)
Coverage46 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Alan Meds

Graded #99 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
YOURx Health

Graded #118 · C

Strengths

  • Lab monitoring included (per the home page) — most peer platforms gate labs as add-ons or skip them entirely
  • Physician video consultation with 'board-certified provider' disclosed
  • MD Integrations network is a recognized white-label clinical platform
  • Transparent published pricing: semaglutide injection $179/mo, tirzepatide injection $199/mo, oral RDT tablets $159-$179/mo

Where it loses points

  • Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
  • NO LegitScript / NABP / PCAB / BBB seal displayed — material trust-signal gap vs peer platforms
  • Per-state availability shown as 'Coverage 0 States' (placeholder metric) — appears the home page is incomplete or the platform is pre-launch
  • Pharmacy partners NOT publicly named
  • Confidence LOW until the platform exposes more public information

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard